| Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer | JCO precision oncology |  | | 2025 | 30 | 106 |
|
| Reporting of somatic variants in clinical cancer care : recommendations of the Swiss Society of Molecular Pathology | Virchows Archiv | | | 2024 | 63 | 141 |
|
| BRCA2 germline mutation carrier with five malignancies : a case report | Hereditary Cancer in Clinical Practice | | | 2024 | 40 | 384 |
|
| High concordance of different assays in the determination of homologous recombination deficiency-associated genomic instability in ovarian cancer | JCO precision oncology | | | 2024 | 121 | 166 |
|
| Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma | JCO precision oncology | | | 2023 | 119 | 174 |
|
| Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab | Gynecologic Oncology Reports | | | 2021 | 272 | 163 |
|
| Automated Detection of Arm-Level Alterations for Individual Cancer Patients in the Clinical Setting | The journal of molecular diagnostics | | | 2021 | 212 | 393 |
|
| Tissue-plasma TMB comparison and plasma TMB monitoring in patients with metastatic non-small cell lung cancer receiving immune checkpoint inhibitors | Frontiers in Oncology | | | 2020 | 304 | 334 |
|
| Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss | Cancer Biology and Therapy | | | 2020 | 363 | 234 |
|
| Targeted RNA-sequencing identifies FBXW4 instead of MGEA5 as fusion partner of TGFBR3 in pleomorphic hyalinizing angiectatic tumor | Virchows Archiv |  | | 2019 | 404 | 0 |
|
| Towards optimal pancreatic cyst fluid management: the need for standardisation | Gut | | | 2018 | 385 | 0 |
|
